Relationship Between Glycemic Control and Diabetes-Related Hospital Costs in Patients with Type 1 or Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Diabetes mellitus requires continuous medical care and patient self-management in order to prevent short-term complications and decrease the risk of long-term complications, which can result in substantial increases in the total economic burden of the disease. Findings from randomized clinical trials have shown that improved glycemic control may reduce the risk of long-term complications as long as a target for hemoglobin A1c is not set below 7% for intensive glycemic control. However, limited data from clinical practice are available regarding the relationship between glycemic control and medical costs associated with diabetes care. OBJECTIVE: To assess the potential relationships between glycemic levels, diabetes-related hospitalizations, and hospital costs among adult patients with either type 1 or type 2 diabetes mellitus who were assigned to a primary care provider (PCP) in a clinic that was affiliated with a managed care organization (MCO). METHODS: A retrospective cohort analysis was conducted using data from approximately 200,000 members of the Fallon Clinic Health Plan who were assigned to a clinic PCP at any time during a 5-year study period beginning January 1, 2002, and ending December 31, 2006. Patients aged 30 years or older with at least 2 medical claims with any listed diagnosis of diabetes mellitus (ICD-9-CM code 250.xx) during the study period and 2 or more A1c values within 1 year of each other during the study period (mean 7.6 tests over 39 months; median=6.8), were identified and stratified into 1 of 5 groups defined by 1% increments of A1c, based on their mean A1c values during the entire study period. A1c data were available only for tests ordered by a clinic provider; tests ordered by other specialists in the MCO's network were absent from the database. The study follow-up period started with each patient's first A1c test (index date) and continued until plan disenrollment, death, or December 31, 2006, whichever was earlier (end date), regardless of when the diagnosis of diabetes mellitus was made. Study measures included the proportion of patients with 1 or more diabetes-related hospitalizations, number of diabetes-related inpatient stays, and the associated estimated hospitalization costs over the follow-up period. Diabetes-related hospitalizations were identified based on a diagnosis, in any of 10 diagnosis fields, for 1 of 16 selected complications of diabetes identified by the authors. Hospital costs were estimated using discharge data (diagnoses and costs calculated from cost-to-charge ratios) contained in the 2004 Healthcare Cost and Utilization Project (HCUP) database and inflated to 2007 dollars using the medical care component of the Consumer Price Index. Multivariate models controlled for age, sex, number of A1c tests, diagnosis of cancer, and follow-up time. A multivariate logistic regression analysis was conducted with the occurrence of at least 1 diabetes-related hospital admission as the dependent variable. In the logistic regression analysis, follow-up time was defined as time from the index date to the date of the first diabetes-related hospitalization, plan disenrollment, death, or the study end date, whichever occurred first. A generalized linear model with a Poisson distribution and a log link was employed to estimate the rate of hospital admissions. In the Poisson regression analysis, follow-up time was defined as duration of the entire study follow-up period and was an offset variable. Costs were estimated using a 2-part model: first, we calculated the probability of having a hospitalization, as determined by the logistic regression above; second, a generalized linear model with a negative binomial distribution and a log link was used to predict the mean cost of diabetes-related hospitalizations only for patients with an inpatient stay, with the duration of the entire study follow-up period as an offset variable. We calculated the mean per patient cost of diabetes-related hospitalizations by multiplying the probability of having a hospitalization (as determined by the first part of the model) by the mean costs for patients who had such admissions (as determined by the second part of the model). RESULTS: 9,887 patients met study selection criteria. Mean A1c level was < 7% for 5,649 (57.1%) patients, 7% to < 8% for 2,747 (27.8%), 8% to < 9% for 1,002 (10.1%), 9% to < 10% for 312 (3.2%), and 10% or more for 177 (1.8%). Over a mean (median) 40 (40) months of follow-up (interquartile range = 30-50 months), 28.7% (n = 2,838) of patients had 1 or more diabetes- related hospital admissions. In the logistic regression analysis, odds of having at least 1 diabetes-related hospital stay did not significantly differ for patients with mean A1c of < 7% compared with patients in most higher mean A1c categories (7% to < 8%, 8% to < 9%, or 9% to < 10%); however, odds of having a diabetes-related hospitalization were significantly higher for patients with mean A1c of 1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Diabetes Care · doi:10.2337/dc08-9026 · Cited by 881
Systematic review: glucose control and cardiovascular disease in type 2 diabetes
Kelly, T. N., Bazzano, L. A., Fonseca, V. A., Thethi, T. K., Reynolds, K., & He, J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-6-200909150-00137 · Cited by 358 · cited 1×
“001 Median (IQR) 7 (4-10) 6 (4-9) 9 (6-12) 8 (5-12) 7 (4-10) 5 (3-7) Patient mean A1c valuea Mean (SD) 7.”
Cited by
Hospital readmission of patients with diabetes
Rubin, D. J. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0584-7 · Cited by 159
Medication adherence and glycemic control among newly diagnosed diabetes patients
Lin, L.-K., Sun, Y., Heng, B. H., Chew, D. E. K., & Chong, P.-N. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000429 · Cited by 123
Schneider, A. L. C., Kalyani, R. R., Golden, S., Stearns, S. C., Wruck, L., Yeh, H. C., Coresh, J., & Selvin, E. (2016) · Diabetes Care · doi:10.2337/dc15-1335 · Cited by 102
Houle, J., Beaulieu, M. ‐., Chiasson, J. ‐., Lespérance, F., Côté, J., Strychar, I., Bherer, L., Meunier, S., & Lambert, J. (2015) · Diabetic Medicine · doi:10.1111/dme.12686 · Cited by 92
Bansal, V., Mottalib, A., Pawar, T. K., Abbasakoor, N., Chuang, E., Chaudhry, A., Sakr, M., Gabbay, R. A., & Hamdy, O. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000460 · Cited by 91
Metadata
- Authors
- Menzin, J., Korn, J. R., Cohen, J., Lobo, F., Zhang, B., Friedman, M., & Newmann, P. J.
- Venue
- Journal of Managed Care Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2010-05
- Volume
- 16
- Issue
- 4
- Pages
- 264-275
- ISSN
- 1083-4087 (ISSN-L)
- 1944-706X
- OpenAlex
- W2136726633
- Cited by
- 165
- References
- 4
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relationship Between Glycemic Control and Diabetes-Related Hospital Costs in Patients with Type 1 or Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.18553/jmcp.2010.16.4.264
- The paper
- Menzin, J., Korn, J. R., Cohen, J., Lobo, F., Zhang, B., Friedman, M., & Newmann, P. J. (2010). Relationship Between Glycemic Control and Diabetes-Related Hospital Costs in Patients with Type 1 or Type 2 Diabetes Mellitus. Journal of Managed Care Pharmacy. https://doi.org/10.18553/jmcp.2010.16.4.264
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.